Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer

Molecular Cancer

Volumn 3, Issue , 2004, Pages

  Arapshian, Alice ^a,c   Bertran, Silvina ^a   Kuppumbatti, Yuvarani S ^a,d   Nakajo, Shigeo ^b   Mira y Lopez, Rafael ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SHOWA UNIVERSITY   (Japan)

^c University of California ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BISULFITE; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; METHYLTRANSFERASE INHIBITOR; RETINOIC ACID; RETINOL BINDING PROTEIN; TRICHOSTATIN A; CELLULAR RETINOL BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROXAMIC ACID; MYC PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE INDUCTION; GENE SILENCING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE; ONCOGENE MYC; ONCOGENE NEU; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TRANSGENIC MOUSE; ANIMAL; BREAST TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR EVOLUTION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; MICE; ONCOGENES; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2; RETINOL-BINDING PROTEINS; RETINOL-BINDING PROTEINS, CELLULAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN;

EID: 2942538294     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-3-13     Document Type: Article

References (42)

1. Chambon P: A decade of molecular biology of retinoic acid receptors. Faseb J 1996, 10:940-54.
2. Wolbach SB, Howe PR: Tissue changes following deprivation of fat soluble A vitamin. J Exp Med 1925, 42:753-777.
3. Thompson JN, Howell JM, Pitt GAJ: Vitamin A and reproduction in rats. Proc Royal Soc 1964, 159:510-535.
4. Ghyselinck NB, Bavik C, Sapin V, Mark M, Bonnier D, Hindelang C, Dierich A, Nilsson CB, Hakansson H, Sauvant P, et al.: Cellular retinol-binding protein I is essential for vitamin A homeostasis. Embo J 1999, 18:4903-14.
5. Bok D: The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl 1993, 17:189-95.
6. Ylikoski J, Pirvola U, Eriksson U: Cellular retinol-binding protein type I is prominently and differentially expressed in the sensory epithelium of the rat cochlea and vestibular organs. J Comp Neurol 1994, 349:596-602.
7. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira-y-Lopez R: Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000, 92:475-80.
8. Ruberte E, Dolle P, Chambon P, Morriss-Kay G: Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 1991, 111:45-60.
9. Smith WC, Nakshatri H, Leroy P, Rees J, Chambon P: A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. Embo J 1991, 10:2223-30.
10. Eskild W, Oyen O, Beebe S, Jahnsen T, Hansson V: Regulation of mRNA levels for cellular retinol binding protein in rat Sertoli cells by cyclic AMP and retinol. Biochem Biophys Res Commun 1988, 152:1504-10.
11. Kroepelien CF, Knutsen HK, Haugen TB, Hansson V, Eskild W: Serum factors induce messenger ribonucleic acid levels for cellular retinol-binding protein in rat Sertoli cells. Endocrinology 1993, 132:968-74.
12. Rush MG, Ul-Haq R, Chytil F: Opposing effects of retinoic acid and dexamethasone on cellular retinol-binding protein ribonucleic acid levels in the rat. Endocrinology 1991, 129:705-9.
13. Xu G, Bochaton-Piallat ML, Andreutti D, Low RB, Gabbiani G, Neuville P: Regulation of alpha-smooth muscle actin and CRBP-1 expression by retinoic acid and TGF-beta in cultured fibroblasts. J Cell Physiol 2001, 187:315-25.
14. Nilsson MH, Spurr NK, Lundvall J, Rask L, Peterson PA: Human cellular retinol-binding protein gene organization and chromosomal location. Eur J Biochem 1988, 173:35-44.
15. Eskild W, Simard J, Hansson V, Guerin SL: Binding of a member of the NF1 family of transcription factors to two distinct cisacting elements in the promoter and 5′-flanking region of the human cellular retinol binding protein 1 gene. Mol Endocrinol 1994, 8:732-45.
16. Kuppumbatti YS, Rexer B, Nakajo S, Nakaya K, Mira-y-Lopez R: CRBP suppresses breast cancer cell survival and anchorage-independent growth. Oncogene 2001, 20:7413-9.
17. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, Herman JG: Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Res 2002, 62:5902-5.
18. Fisher GJ, Reddy AP, Datta SC, Kang S, Yi JY, Chambon P, Voorhees JJ: All-trans retinoic acid induces cellular retinol-binding protein in human skin in vivo. J Invest Dermatol 1995, 105:80-6.
19. Minucci S, Horn V, Bhattacharyya N, Russanova V, Ogryzko VV, Gabriele L, Howard BH, Ozato K: A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. Proc Natl Acad Sci USA 1997, 94:11295-300.
20. Mira-y-Lopez R, Zheng WL, Kuppumbatti YS, Rexer B, Jing Y, Ong DE: Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. J Cell Physiol 2000, 185:302-9.
21. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-y-Lopez R: Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 2002, 13:335-41.
22. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-6.
23. Singer J, Roberts-Ems J, Riggs AD: Methylation of mouse liver DNA studied by means of the restriction enzymes msp I and hpa II. Science 1979, 203:1019-21.
24. Morrison BW, Leder P: neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994, 9:3417-26.
25. Morrison AJ, Herrera RE, Heinsohn EC, Schiff R, Osborne CK: Dominant Negative N-CoR Relieves Transcriptional Inhibition of Retinoic Acid Receptor but Does Not Alter the Agonist/Antagonist Activities of the Tamoxifen-bound Estrogen Receptor. Mol Endocrinol 2003.
26. Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-81.
27. Wang J, Hannon GJ, Beach DH: Risky immortalization by telomerase. Nature 2000, 405:755-6.
28. Bartek J, Bartkova J, Kyprianou N, Lalani EN, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J: Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci U S A 1991, 88:3520-4.
29. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, et al.: A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004, 6:308-18.
30. Baylin S, Bestor TH: Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 2002, 1:299-305.
31. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, et al.: Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 2003, 100:15853-8.
32. Yang X, Yan L, Davidson NE: DNA methylation in breast cancer. Endocr Relat Cancer 2001, 8:115-27.
33. Deming SL, Nass SJ, Dickson RB, Trock BJ: C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 2000, 83:1688-95.
34. Guo X, Ruiz A, Rando RR, Bok D, Gudas LJ: Esterification of all trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin: rctinol acyltransferase in carcinoma lines. Carcinogenesis 2000, 21:1925-33.
35. Rexer BN, Zheng WL, Ong DE: Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res 2001, 61:7065-70.
36. Triano EA, Slusher LB, Atkins TA, Beneski JT, Gestl SA, Zolfaghari R, Polavarapu R, Frauenhoffer E, Weisz J: Class I Alcohol Dehydrogenase Is Highly Expressed in Normal Human Mammary Epithelium but not in Invasive Breast Cancer: Implications for Breast Carcinogenesis. Cancer Res 2003, 63:3092-100.
37. Chen LI, Sommer KM, Swisshelm K: Downstream codons in the retinoic acid receptor beta -2 and beta -4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription. J Biol Chem 2002, 277:35411-21.
38. Arapshian A, Kuppumbatti YS, Mira-y-Lopez R: Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Oncogene 2000, 19:4066-70.
39. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992, 89:1827-31.
40. Clark SJ, Harrison J, Paul CL, Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994, 22:2990-7.
41. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-54.
42. Busch C, Sakena P, Funa K, Nordlinder H, Eriksson U: Tissue distribution of cellular retinol-binding protein and cellular retinoic acid-binding protein: use of monospecific antibodies for immunohistochemistry and cRNA for in situ localization of mRNA. Methods Enzymol 1990, 189:315-24.